At Alimentiv, we specialize in providing advanced medical imaging solutions that meet the unique needs of Gastroenterology (GI) clinical trials. Our CIMS Endoscopy technology is a leading solution for central image management in global clinical trials, providing standardized video acquisition, quality control, and expert assessment of endoscopic disease activity by gastroenterologists.

As the pioneer in developing, validating, and implementing endoscopic central imaging solutions in IBD clinical trials, we have been providing this solution since 2007, and it has become the global leader in central endoscopy reading services. Our research has shown that central reading reduces the placebo response and increases data quality.

In 2023 a significant enhancement to the CIMS technology was completed to add high-definition (HD) video capture capability in response to new draft guidance from the FDA on developing drugs for the treatment of Ulcerative Colitis and Crohn’s disease. We are the first service provider to bring an HD video capture solution designed specifically for clinical trials to the market.

Our CIMS Endoscopy technology offers a range of features and benefits that make it the perfect solution for your clinical trial, including:

  • Customization to meet your clinical trial protocol requirements
  • Compliance with FDA 21 CFR part 11 and other regulatory standards
  • Secure and encrypted video recordings
  • Compatible with endoscopy video processing units in use in over 60 countries around the world
  • Easy to set up with a simple user interface and real-time verification of video capture

CIMSPLUS technology is designed to make the process of endoscopic imaging in clinical trials more efficient, reliable, and accurate to help you achieve success in your clinical trial. With our expert team of professionals, you can rest assured that your endoscopic imaging needs are in good hands.

CIMSPLUS is the enhanced version of Alimentiv’s industry-leading CIMS Endoscopy video capture and viewing technology. The launch of this viewing technology was designed to meet the unique needs of Gastroenterology (GI) clinical trials. CIMSPLUS offers standardized video acquisition, quality control, and expert assessment of endoscopic disease activity by gastroenterologists, with added benefits over the original CIMS solution.

Indications:

  • Crohn’s Disease
  • Ulcerative Colitis
  • Pouchitis
  • Eosinophilic Gastrointestinal Disease (EGID)

Scoring Indices:

  • SES-CD
  • CDEIS
  • UCEIS
  • Mayo Endoscopic Subscore (MES)
  • Modified Mayo Score
    EREFS

Don’t let inadequate imaging hold you back from developing new treatments for Gastroenterology (GI) health conditions. Choose Alimentiv’s CIMS Endoscopy technology for a reliable and innovative solution that will support the success of your clinical trial. Contact our business development team to learn more about how we can help.

Back